High-Throughput Genome Editing for Disease Models

Tue19  Oct04:20pm(5 mins)
Hall 1C
 Nick Clare


Genome engineering can greatly enhance successful drug discovery. CRISPR is quickly proving to be the tool for the job, with its precision editing capabilities and minimal off-target effects. Leveraging the power of CRISPR can accelerate progress across the drug discovery pipeline and ultimately lead to more and better-validated
drugs entering the clinic. Knowing the genetic landscape of a drug target increases its chances of success by two-fold! Leveraging automated platforms, Synthego provides high throughput CRISPR solutions for basic research, target identification and validation, disease modeling, and preclinical studies. As an example, we’ll show here how Synthego supported the NIH in the iPSC Neurodegeneration Initiative (iNDI) project.
To view the video assoicated with this lecture click here

Hosted By

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Find us on Facebook Follow us on Twitter

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG, eventflo.co.uk, Labhoo Ltd 2003-2021